Literature DB >> 12223043

Will pharmacogenomics alter the role of patents in drug development?

Rebecca S Eisenberg.   

Abstract

Mesh：

Year:  2002        PMID： 12223043     DOI： 10.1517/14622416.3.5.571

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  5 in total

1.  Accelerating drug discovery.

Authors:  Sandra Kraljevic; Peter J Stambrook; Kresimir Pavelic
Journal:  EMBO Rep       Date:  2004-09       Impact factor: 8.807

2.  Developing products for personalized medicine: NIH Research Tools Policy applications.

Authors:  Ranjan Gupta; Jp Kim; Jack Spiegel; Steven M Ferguson
Journal:  Per Med       Date:  2004-12-01       Impact factor: 2.512

Review 3.  Pharmacogenomics in early-phase clinical development.

Authors:  Tal Burt; Savita Dhillon
Journal:  Pharmacogenomics       Date:  2013-07       Impact factor: 2.533

4.  A Decade of Pharmacogenetic Studies in Jordan: A Systemic Review.

Authors:  Alaa Yehya; Zaid Altaany
Journal:  Pharmacogenomics J       Date:  2021-04-13       Impact factor: 3.550

Review 5.  Shifting emphasis from pharmacogenomics to theragnostics.

Authors:  Vural Ozdemir; Bryn Williams-Jones; Stephen J Glatt; Ming T Tsuang; James B Lohr; Christopher Reist
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.